EURX Eurand N.V. (MM)

Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that Gearóid Faherty, Chairman and Chief Executive Officer, is scheduled to present at the Jefferies 2010 Global SpecPharma and European Healthcare Conference. Details are as follows:

Date:  Tuesday, October 5, 2010
Time:  9:00 a.m. Local Time
Place: The Waldorf Hilton
       London, England

A live audio webcast of the presentation can be accessed in the investor relations section of Eurand's web site at www.eurand.com and will be available via replay for 30 days.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.

Contacts: Bill Newbould Vice President, Investor Relations Eurand N.V. +1 267-759-9335 Email Contact Nick Laudico/Sara Pellegrino The Ruth Group +1 646-536-7030/7002 Email Contact Email Contact